Anti-Immunoglobulin E Therapy for Asthma

This publication has 39 references indexed in Scilit:

• Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality
  Current Medical Research and Opinion, 2001
• Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
  Journal of Allergy and Clinical Immunology, 2001
• The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice
  Clinical and Experimental Allergy, 2000
• Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
  New England Journal of Medicine, 1999
• IgE Enhances Mouse Mast Cell FcεRI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions
  The Journal of Experimental Medicine, 1997
• Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.
  The Journal of Experimental Medicine, 1996
• Negative feedback regulation of IgE synthesis by murine CD23
  Nature, 1994
• Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.
  Thorax, 1992
• Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens
  New England Journal of Medicine, 1989
• The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma
  Journal of Allergy and Clinical Immunology, 1987